Interleukin-10 (IL-10) genotypes in inflammatory bowel disease

Tissue Antigens

Volumn 54, Issue 4, 1999, Pages 386-390

  Tagore, A ^a   Gonsalkorale, W M ^b   Pravica, V ^a   Hajeer, A H ^c   McMahon, R ^a   Whorwell, P J ^b   Sinnott, P J ^a   Hutchinson, I V ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biallelic; Crohn's disease; IBD; IL 10; Polymorphisms; Ulcerative colitis

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOKINE; INTERLEUKIN 10;

ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DNA DETERMINATION; ENTERITIS; GENETIC PREDISPOSITION; GENETIC REGULATION; GENOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; CONCANAVALIN A; CROHN DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-10; LEUKOCYTES; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 0032864071     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.540408.x     Document Type: Article

References (30)

1. Goldman H. Interpretation of large intestinal mucosal biopsy specimens. Hum Pathol 1994: 25: 1150-9.
2. Jenkins D, Balsitis M, Gallivan S et al. Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathology 1997: 50: 93-105.
3. Duchmann R, Neurath M, Marker Hermann E, Meyer Zum Buschenfelder KH. Immune responses towards intestinal bacteria - current concepts and future perspectives. Z-Gastroenterol 1997: 35: 337-46.
4. Reif S, Klein T, Lubin F, Farbstein M, Hallak A, Gillat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997: 40: 754-60.
5. Cahill RJ, Foltz CF, Fox JG, Dangler CA, Powrie F, Schauer DB. Inflammatory bowel disease: an immunity-mediated condition triggered by bacterial infection with Helicobacter hepaticus. Infect Immun 1997: 65: 3126-31.
6. MacMermott RP. Alterations of the mucosal immune system in inflammatory bowel disease. J Gastroenterol 1996: 31: 907-16.
7. Armstrong AM, Gardiner KR, Kirk SJ, Halliday MI, Rowlands BJ. Tumour necrosis factor and inflammatory bowel disease. Br J Surg 1997: 84: 1051-8.
8. Van Hogezand RA, Verspaget HW. New therapies for inflammatory bowel disease: an update on chimeric anti-TNF-alpha antibodies and IL-10 therapy. Scand J Gastroenterol Suppl 1997: 223: 105-7.
9. Cominelli F, Pizarro TT. Interleukin-1 and interleukin-1 receptor antagonist in inflammatory bowel disease. Aliment Pharmacol Ther 1996: 10 (Suppl 2): 49-53.
10. Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995: 108: 1434-44.
11. MacDonald TT. Gastrointestinal inflammation: Inflammatory bowel disease in knockout mice. Curr Biol 1994: 4: 261-3.
12. Davidson NJ, Leach MW, Fort MM et al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin-10deficient mice. J Exp Med 1996: 184: 241-51.
13. Dieleman LA, Pena AS, Meuwissen SG, van Rees EP. Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1997: 223: 99-104.
14. Podolsky DK. Lessons from genetic models of inflammatory bowel disease. Acta Gastroenterol Belg 1997: 60: 163-5.
15. Rhodes J, Thomas G, Evans BK. Inflammatory bowel disease management: Some thoughts on future developments. Drugs 1997: 53: 189-94.
16. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenetics 1997; 24: 1-8.
17. Crawley E, Kay R, Silliborne J, Patel P, Hutchinson IV, Woo P. Polymorphic haplotypes of the IL-10 5′ flanking region determine variable IL-10 transcription and arc associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999: 42: 1011-8.
18. Best WR, Becktel JM, Singleton JR, Kern Jr F. Development of Crohn's Disease Activity Index. Gastroenterology 1976: 70: 439-44.
19. Rachemilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J 1989: 298: 82-6.
20. Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WER, Hutchinson IV Genetic variation in the interleukin-10 gene promoter and systemic lupus erythematosus. J Rheumatol 1997: 24: 2314-7.
21. Parkes M, Satsangi J, Jewell D. Contribution of the IL-2 and IL-10 genes to inflammatory bowel disease (IBD) susceptibility. Clin Exp Immunol 1998: 113: 28-32.
22. Mullin GE, Maycon ZR, Braunelwert L et al. Inflammatory bowel disease mucosal biopsies have specialised messenger RNA profiles. Inflamm Bowel Dis 1996: 2: 16-26.
23. Nielsen OH, Koppen T, Rudiger N, Horn T, Eriksen J, Kirman I. Involvement of interleukin-4 and -10 in inflammatory bowel disease. Dig Dis Sci 1996: 41: 1786-93.
24. Niessner M, Volk BA. Altered Th1-Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995: 101: 428-35.
25. Kucharzik T, Stoll R, Lugering N, Domschke W, Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995: 100: 452-26.
26. Kulkarni AB. Tansforming growth factor beta-1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993: 90: 770-4.
27. Turner D, Grant SC, Yonan N et al. Cytokine gene polymorphism and heart transplant rejection. Transplantation 1997: 64: 776-9.
28. Sankaran D, Ashraf S, Asderakis A et al. Tumour necrosis factor-α and interleukin-10 gene polymorphisms predict acute renal allograft rejection. Kidney Int 1999: in press.
29. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production correlates with a CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet 1999: 26: 1-3.
30. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnolt PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 60: 1014-20.